IBDEI0Q1 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11704,1,4,0)
 ;;=4^K76.7
 ;;^UTILITY(U,$J,358.3,11704,2)
 ;;=^56497
 ;;^UTILITY(U,$J,358.3,11705,0)
 ;;=N00.0^^46^573^8
 ;;^UTILITY(U,$J,358.3,11705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11705,1,3,0)
 ;;=3^Acute nephritic syndrome w/ minor glomerular abnormality
 ;;^UTILITY(U,$J,358.3,11705,1,4,0)
 ;;=4^N00.0
 ;;^UTILITY(U,$J,358.3,11705,2)
 ;;=^5015491
 ;;^UTILITY(U,$J,358.3,11706,0)
 ;;=N00.1^^46^573^7
 ;;^UTILITY(U,$J,358.3,11706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11706,1,3,0)
 ;;=3^Acute nephritic syndrome w/ focal and segmental glomerular lesions
 ;;^UTILITY(U,$J,358.3,11706,1,4,0)
 ;;=4^N00.1
 ;;^UTILITY(U,$J,358.3,11706,2)
 ;;=^5015492
 ;;^UTILITY(U,$J,358.3,11707,0)
 ;;=N00.2^^46^573^4
 ;;^UTILITY(U,$J,358.3,11707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11707,1,3,0)
 ;;=3^Acute nephritic syndrome w/ diffuse membranous glomrlneph
 ;;^UTILITY(U,$J,358.3,11707,1,4,0)
 ;;=4^N00.2
 ;;^UTILITY(U,$J,358.3,11707,2)
 ;;=^5015493
 ;;^UTILITY(U,$J,358.3,11708,0)
 ;;=N00.3^^46^573^5
 ;;^UTILITY(U,$J,358.3,11708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11708,1,3,0)
 ;;=3^Acute nephritic syndrome w/ diffuse mesangial prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,11708,1,4,0)
 ;;=4^N00.3
 ;;^UTILITY(U,$J,358.3,11708,2)
 ;;=^5015494
 ;;^UTILITY(U,$J,358.3,11709,0)
 ;;=N00.4^^46^573^3
 ;;^UTILITY(U,$J,358.3,11709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11709,1,3,0)
 ;;=3^Acute nephritic syndrome w/ diffuse endocaplry prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,11709,1,4,0)
 ;;=4^N00.4
 ;;^UTILITY(U,$J,358.3,11709,2)
 ;;=^5015495
 ;;^UTILITY(U,$J,358.3,11710,0)
 ;;=N00.5^^46^573^6
 ;;^UTILITY(U,$J,358.3,11710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11710,1,3,0)
 ;;=3^Acute nephritic syndrome w/ diffuse mesangiocap glomrlneph
 ;;^UTILITY(U,$J,358.3,11710,1,4,0)
 ;;=4^N00.5
 ;;^UTILITY(U,$J,358.3,11710,2)
 ;;=^5015496
 ;;^UTILITY(U,$J,358.3,11711,0)
 ;;=N00.6^^46^573^1
 ;;^UTILITY(U,$J,358.3,11711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11711,1,3,0)
 ;;=3^Acute nephritic syndrome w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,11711,1,4,0)
 ;;=4^N00.6
 ;;^UTILITY(U,$J,358.3,11711,2)
 ;;=^5015497
 ;;^UTILITY(U,$J,358.3,11712,0)
 ;;=N00.7^^46^573^2
 ;;^UTILITY(U,$J,358.3,11712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11712,1,3,0)
 ;;=3^Acute nephritic syndrome w/ diffuse crescentic glomrlneph
 ;;^UTILITY(U,$J,358.3,11712,1,4,0)
 ;;=4^N00.7
 ;;^UTILITY(U,$J,358.3,11712,2)
 ;;=^5015498
 ;;^UTILITY(U,$J,358.3,11713,0)
 ;;=N00.8^^46^573^9
 ;;^UTILITY(U,$J,358.3,11713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11713,1,3,0)
 ;;=3^Acute nephritic syndrome w/ other morphologic changes
 ;;^UTILITY(U,$J,358.3,11713,1,4,0)
 ;;=4^N00.8
 ;;^UTILITY(U,$J,358.3,11713,2)
 ;;=^5015499
 ;;^UTILITY(U,$J,358.3,11714,0)
 ;;=N00.9^^46^573^10
 ;;^UTILITY(U,$J,358.3,11714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11714,1,3,0)
 ;;=3^Acute nephritic syndrome w/ unsp morphologic changes
 ;;^UTILITY(U,$J,358.3,11714,1,4,0)
 ;;=4^N00.9
 ;;^UTILITY(U,$J,358.3,11714,2)
 ;;=^5015500
 ;;^UTILITY(U,$J,358.3,11715,0)
 ;;=N01.0^^46^573^69
 ;;^UTILITY(U,$J,358.3,11715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11715,1,3,0)
 ;;=3^Rapidly progr neph synd w/ minor glomerular abnlt
 ;;^UTILITY(U,$J,358.3,11715,1,4,0)
 ;;=4^N01.0
 ;;^UTILITY(U,$J,358.3,11715,2)
 ;;=^5015501
 ;;^UTILITY(U,$J,358.3,11716,0)
 ;;=N01.1^^46^573^68
